SEC FORM 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:		3235-0287
Expires:	December 31, 2014
Estimated average burden
hours per response:		0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person ^*

WINTER JOHN M

(Last)

(First)

(Middle)

1550 WEWATTA STREET

SUITE 800

(Street)

DENVER

80202

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Liberty Latin America Ltd. [ LILA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
SVP, CLO AND SECRETARY

3. Date of Earliest Transaction (Month/Day/Year)
06/17/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Share Units P	⁽¹⁾	06/17/2026		J	V	6,298 ⁽²⁾		03/15/2027	03/15/2027	Series A Preference Shares	6,298 ⁽²⁾	$ 0	6,298	D
Restricted Share Units P	⁽¹⁾	06/17/2026		J	V	11,962 ⁽²⁾		⁽³⁾	⁽³⁾	Series A Preference Shares	11,962 ⁽²⁾	$ 0	11,962	D
Restricted Share Units P	⁽¹⁾	06/17/2026		J	V	15,483 ⁽²⁾		⁽⁴⁾	⁽⁴⁾	Series A Preference Shares	15,483 ⁽²⁾	$ 0	15,483	D
Share Appreciation Rights A	$ 15.1							⁽⁵⁾	01/02/2028	Class A Common Shares	16,951 ⁽⁶⁾		16,951	D
Share Appreciation Rights C	$ 14.56							⁽⁵⁾	01/02/2028	Class C Common Shares	34,850 ⁽⁷⁾		34,850	D
Share Appreciation Rights A	$ 13.03							⁽⁵⁾	05/01/2028	Class A Common Shares	34,480 ⁽⁸⁾		34,480	D
Share Appreciation Rights C	$ 12.41							⁽⁵⁾	05/01/2028	Class C Common Shares	70,889 ⁽⁹⁾		70,889	D
Share Appreciation Rights A	$ 13.93							⁽⁵⁾	05/01/2029	Class A Common Shares	33,778 ⁽¹⁰⁾		33,778	D
Share Appreciation Rights C	$ 13.63							⁽⁵⁾	05/01/2029	Class C Common Shares	69,445 ⁽¹¹⁾		69,445	D
Share Appreciation Rights A	$ 7.29							⁽⁵⁾	03/16/2030	Class A Common Shares	60,702 ⁽¹²⁾		60,702	D
Share Appreciation Rights C	$ 7.13							⁽⁵⁾	03/16/2030	Class C Common Shares	124,800 ⁽¹³⁾		124,800	D
Share Appreciation Rights A	$ 9.8							⁽⁵⁾	03/16/2031	Class A Common Shares	86,178 ⁽¹⁴⁾		86,178	D
Share Appreciation Rights C	$ 9.6							⁽⁵⁾	03/16/2031	Class C Common Shares	177,179 ⁽¹⁵⁾		177,179	D
Share Appreciation Rights A	$ 9.8							⁽⁵⁾	03/16/2031	Class A Common Shares	143,000 ⁽¹⁶⁾		143,000	D
Share Appreciation Rights C	$ 9.6							⁽⁵⁾	03/16/2031	Class C Common Shares	294,000 ⁽¹⁷⁾		294,000	D
Share Appreciation Rights A	$ 6.78							⁽⁵⁾	03/11/2032	Class A Common Shares	132,315 ⁽¹⁸⁾		132,315	D
Share Appreciation Rights C	$ 6.56							⁽⁵⁾	03/11/2032	Class C Common Shares	272,032 ⁽¹⁹⁾		272,032	D
Share Appreciation Rights A	$ 5.47							⁽⁵⁾	03/20/2033	Class A Common Shares	137,467 ⁽²⁰⁾		137,467	D
Share Appreciation Rights C	$ 5.3							⁽⁵⁾	03/20/2033	Class C Common Shares	282,625 ⁽²¹⁾		282,625	D
Share Appreciation Rights A	$ 4.31							⁽²²⁾	03/12/2034	Class A Common Shares	170,491 ⁽²³⁾		170,491	D
Share Appreciation Rights C	$ 4.24							⁽²²⁾	03/12/2034	Class C Common Shares	350,521 ⁽²⁴⁾		350,521	D
Share Appreciation Rights A	$ 4.68							⁽²⁵⁾	03/14/2035	Class A Common Shares	157,575 ⁽²⁶⁾		157,575	D
Share Appreciation Rights C	$ 4.54							⁽²⁵⁾	03/14/2035	Class C Common Shares	323,965 ⁽²⁷⁾		323,965	D
Share Appreciation Rights A	$ 5.31							⁽²⁸⁾	03/13/2036	Class A Common Shares	139,512 ⁽²⁹⁾		139,512	D
Share Appreciation Rights C	$ 5.29							⁽²⁸⁾	03/13/2036	Class C Common Shares	286,829 ⁽³⁰⁾		286,829	D

Explanation of Responses:

1. Each Restricted Share Unit P ("RSU") represents a right to receive one share of the Issuer's Series A Preference Shares at settlement.

2. In connection with the Dividend (as defined in Remarks), all RSUs with respect to the Issuer's common stock ("Original RSUs") were adjusted pursuant to the anti-dilution provisions of the incentive plans under which the RSU awards held by the reporting person were granted. Each holder of an Original RSU was entitled to receive an RSU with respect to a number of Preferred Shares equal to 0.10 multiplied by the number of shares of common stock underlying the Original RSU, subject to the same terms and conditions as the Original RSU. These adjustments were approved by the Issuer's board of directors pursuant to Rule 16b-3.

3. The RSUs vest in two equal annual installments on March 15 of 2027 and 2028.

4. The RSUs vest in three equal annual installments on March 15 of 2027, 2028 and 2029.

5. The derivative security is fully vested.

6. This share appreciation right award ("SAR") was previously reported as a SAR relating to 11,854 shares of the Issuer's common stock at a base price of $21.58 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.

7. This SAR was previously reported as a SAR relating to 23,708 shares of the Issuer's common stock at a base price of $21.39 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.

8. This SAR was previously reported as a SAR relating to 24,112 shares of the Issuer's common stock at a base price of $18.63 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.

9. This SAR was previously reported as a SAR relating to 48,224 shares of the Issuer's common stock at a base price of $18.24 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.

10. This SAR was previously reported as a SAR relating to 23,621 shares of the Issuer's common stock at a base price of $19.91 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.

11. This SAR was previously reported as a SAR relating to 47,242 shares of the Issuer's common stock at a base price of $20.03 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.

12. This SAR was previously reported as a SAR relating to 42,449 shares of the Issuer's common stock at a base price of $10.42 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.

13. This SAR was previously reported as a SAR relating to 84,898 shares of the Issuer's common stock at a base price of $10.48 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.

14. This SAR was previously reported as a SAR relating to 60,265 shares of the Issuer's common stock at a base price of $14.00 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.

15. This SAR was previously reported as a SAR relating to 120,530 shares of the Issuer's common stock at a base price of $14.10 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.

16. This SAR was previously reported as a SAR relating to 100,000 shares of the Issuer's common stock at a base price of $14.00 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.

17. This SAR was previously reported as a SAR relating to 200,000 shares of the Issuer's common stock at a base price of $14.10 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.

18. This SAR was previously reported as a SAR relating to 92,528 shares of the Issuer's common stock at a base price of $9.69 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.

19. This SAR was previously reported as a SAR relating to 185,056 shares of the Issuer's common stock at a base price of $9.63 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.

20. This SAR was previously reported as a SAR relating to 96,131 shares of the Issuer's common stock at a base price of $7.81 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.

21. This SAR was previously reported as a SAR relating to 192,262 shares of the Issuer's common stock at a base price of $7.78 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.

22. The SARs vest in full on March 15 of 2027.

23. This SAR was previously reported as a SAR relating to 119,225 shares of the Issuer's common stock at a base price of $6.16 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.

24. This SAR was previously reported as a SAR relating to 238,450 shares of the Issuer's common stock at a base price of $6.22 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.

25. The SARs vest in two equal annual installments on March 15 of 2027 and 2028.

26. This SAR was previously reported as a SAR relating to 110,193 shares of the Issuer's common stock at a base price of $6.69 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.

27. This SAR was previously reported as a SAR relating to 220,385 shares of the Issuer's common stock at a base price of $6.66 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.

28. The Share Appreciation Rights vest in three equal annual installments on March 15 of 2027, 2028 and 2029.

29. This SAR was previously reported as a SAR relating to 97,561 shares of the Issuer's common stock at a base price of $7.58 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.

30. This SAR was previously reported as a SAR relating to 195,122 shares of the Issuer's common stock at a base price of $7.77 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.

Remarks:

On May 21, 2026, the Issuer announced that an authorized committee of the Issuer's board of directors declared a special dividend on each of its outstanding common shares payable on June 16, 2026 to all holders of record as of 5:00 p.m., New York City time, on June 1, 2026 consisting of a special dividend of 0.10 shares of newly issued 9.0% Fixed Rate Cumulative Perpetual Redeemable Series A Preferred Shares (the "Series A Preference Shares"), having an initial liquidation price of $25 per Preferred Share (the "Dividend").

The trading symbols for the Issuer's classes of common shares are LILA, LILAB, and LILAK, and the trading symbol for the Issuer's Series A Preference Shares is LILAP.

	/s/ John M. Winter	07/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.